N-Formyl dipeptide conjugates of ampicillin and amoxicillin related to the chemotactic peptide Nfotmyl-L-methionyl-L-leucyl-L-phenylalanine were synthesized and assessed for antibacterial activity and affinity for the chemotactic peptide receptor of differentiated human promyelocytic leukemia (HL-60) cells. The conjugates and parent P-lactam antibiotics showed similar antibacterial activities against Escherichia coi and Staphylococcus aureus. The affinity of each conjugate for the chemotactic peptide receptor was determined in a competitive binding assay, using 3H-labeled N-formyl-L-methionyl-L-leucyl-L-phenylalanine. All conjugates bound to the receptor, but with affinities ranging from 1/3 to 1/100 that of the tritiated substrate. There was good correlation between receptor affinity and stimulation of chemotaxis. The peptide-antibiotic conjugates also stimulated the oxidative metabolism of the HL-60 cells by inducing the production of superoxide and hydrogen peroxide as determined by Luminol-and Lucigenin-enhanced chemiluminescence. These conjugates, based on N-formyl-L-methionyl-L-leucyl-L-phenylalanine, thus combine both potent antibacterial and immunostimulatory properties within the same molecule.
The ability of cells such as polymorphonuclear leukocytes to phagocytose and kill microorganisms constitutes the first line of host defense against invading bacteria (31, 33) . However, the susceptibility of microorganisms to host defense mechanisms may be increased as a result of antibioticinduced damage to the bacterial cell envelope (1, 16, 20, 35) . In addition, some antibiotics may modulate the phagocytic process directly by influencing leukocyte cheemotaxis, phagocytic uptake, and killing (2, 3, 6, 19, 20, 34) . Such antibiotics exert a much greater therapeutic effect than that predicted by their in vitro bactericidal activity (2, 16, 20) . Thus, the interaction between phagocytic cells and antimicrobial agents is of crucial importance in the eradication of bacterial infections. Consequently, the influence of antibiotics on the effectiveness of the immune response has attracted considerable interest (19) (20) (21) . Antibiotics which stimulate the immune system should offer considerable advantages in aiding the elimination of infecting organisms, especially in immunocompromised patients.
Neutrophils and monocytes respond chemotactically to low-molecular-weight peptides present in bacterial culture supernatants. These peptides, which possess a blocked amino terminus but a free carboxyl terminus, are thought to be derived from newly synthesized proteins since procaryotic cells initiate protein synthesis with N-formyl-Lmethionine (18, 24, 29) . N-Formylated peptides such as N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) induce leukocyte chemotaxis and, at higher concentrations, secretion of enzymes such as lysozyme from cellular organelles. They also stimulate the release of toxic intermediates ofoxygen reduction (9, 12, 24) and promote the phagocytosis anid intracellular killing of bacteria (14) . These responses are initiated by binding of the chemotactic peptides to specific receptors on the leukocyte cell membrane (9, 12, 18, 24, 36 This paper reports the synthesis and in vitro evaluation of N-formyl peptide conjugates of ampiciflin and amoxicillin. To investigate the immunostimulatory properties of these conjugates, the human promyelocytic cell line HL-60, which has the potential to differentiate along either a granulocyte or macrophage lineage, was used (18, 22, 23) . Dimethyl sulfoxide (DMSO) or retinoic acid induces the differentiation of HL-60s along the myeloid lineage, while la,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl-13-phorbol acetate induces a monocyte or macrophage lineage (22) . In this study, DMSO induction was used since DMSO-treated HL-60 cells differentiate into mature granulocytes which express functional receptors for N-formyl peptides (10, 12, 18, 25, 28) , respond chemotactically, and are capable of phagocytosing and killing bacteria (23) .
(This work was presented in part at the 20th European Peptide Symposium, Tilbingen, Federal Republic of Germany, 4 through 10 September 1988.)
MATERIALS AND METHODS
Synthesis of N-formylated peptide-antibiotic conjugaies. The detailed synthesis of N-Form-L-Met-L-Leu-ampicillin is described below; similar methods were used to prepare other N-formyl peptide-antibiotic conjugates.
A solution of N-Form-L-Met-L-Leu (1.5 g) and N-hydroxysuccinimide (0.6 g) in dry dimethoxyethane (50 ml) was cooled to 0WC, and a solution of dicyclohexylcarbodiimide (1.06 g) in dimethoxyethane (10 ml) was added. The mixture was stirred at 0°C for 3 h, and then a solution of ampicillin sodium (2.0 g) in water (20 ml) MIC determination. MICs of each compound were determined against Escherichia coli lAll and Staphylococcus aureus F/21 by tube dilution after overnight growth in nutrient broth at 37°C.
Maintenance and differentiation of HL-60 cells. HL-60 cells were kindly supplied by J. Traynor, University of Loughborough, Loughborough, Leicester, United Kingdom, and were maintained at 37°C in 95% air-5% CO2 in RPMI 1640 medium supplemented with 10% (vol/vol) calf serum, 2 mM L-glutamine, penicillin (50 IU/ml), and streptomycin (50 jig/ml) ( All tubes were cooled in ice water for 5 min before rapid filtration through Whatman GF/A glass-fiber filters and washing with 10 ml of assay buffer (4°C). The filters were added to scintillation vials containing 5 
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probes Luminol (5-amino-2,3-dihydro-1,4-phthalazinedione; Sigma) and Lucigenin (N,N'-dimethyl-10,10'-biacridinium dinitrate; Sigma) were used at a concentration of 10-4 M each to estimate the production of H202 and 02-, respectively (7, 8) .
Briefly, 106 cells in 200 ,ul of assay buffer (phosphatebuffered saline, pH 7.4, 37°C) were added to cuvettes containing Luminol or Lucigenin (200 p.1; 300 ,uM) and various concentrations of peptide or peptide-antibiotic conjugate (200 p.l), maintained at 37°C.
The time course and magnitude of oxidative metabolite production were monitored with a luminometer (LKB model 1250) linked to a chart recorder.
Responses were expressed as percentages of the maximum response produced by a saturating concentration of FMLP (1 p.M). . After a 90-min incubation at 37°C, the filters were removed, fixed in glutaraldehyde, and stained with hematoxylin. Chemotaxis was quantified by counting the number of cells which had migrated completely through the filter in four low-power (x200) microscopic fields.
RESULTS
The structure of each of the four peptide-antibiotic conjugates synthesized is shown in Fig. 1 Interestingly, replacement of the L-leucine residue by D-leucine or ct-aminoisobutyric acid (Aib) increased the activity of the ampicillin conjugates against S. aureus (Table  2) . Against E. coli, however, the MIC was not affected by the leucine stereochemistry, although N-Form-L-Met-DLeu-amoxicillin was considerably less antibacterial than the corresponding ampicillin derivative ( Table 2) .
Receptor binding. HL-60 cells transferred to medium containing DMSO were examined daily for the ability to bind FMLP and to exhibit an oxidative burst. Maximal expression of the receptor and respiratory burst was observed after 10 days of incubation in the presence of DMSO. Cells induced for 10 days were therefore chosen for all subsequent experiments.
[3H]FMLP did not bind (or stimulate the oxidative burst) in undifferentiated HL-60 cells.
All of the conjugates exhibited affinity for the formyl peptide receptor on d-HL-60 cells, as shown by the ability to displace [3H]FMLP from the cells (Fig. 2) . Concentrations of peptide required to produce 50o of the maximum effect, as determined by the concentration curve (ED50s), for the conjugates varied from 4.0 to 126 nM compared with 1.3 nM for FMLP (Table 3) . Thus, the potency of the compounds varied from approximately 1/3 that of FMLP for N-Form-L-Met-L-Leu-ampicillin to approximately 1/100 that of FMLP for N-Form-L-Met-Aib-ampicillin (Table 3) .
Respiratory burst. Figure 3 shows the kinetics of luminolenhanced chemiluminescence response of d-HL-60 cells exposed to a range of FMLP concentrations. A rapid response (within 20 s), reaching a maximum of 15.9 + 0.3 mV, was observed, which quickly decayed. Undifferentiated HL-60 cells showed no response.
Stimulation of .02-and H202 production by the compounds was dose dependent, with ED50s varying from 160.0 to 3,310 nM and from 183 to 3,800 nM, respectively (Fig. 4) . Furthermore, the rank order of potency for the conjugates in stimulating the respiratory burst was the same as that for (Table  3 ). However, a dual effect was observed in that the chemotactic agent produced an increase in the numbers of cells migrating into the filters up to a critical concentration; at higher concentrations, ligand diffused so rapidly across the membrane that no concentration gradient was established (Fig. 5) .
ED50s for the conjugates ranged from 13.2 to 417.0 nM compared with an ED50 of 3.3 nM for FMLP. The rank order of chemotactic activity of the conjugates was the same as that for receptor binding, but the concentrations required for chemotactic activity were approximately three to four times higher (Table 3) .
DISCUSSION
Ligand binding to the chemotactic peptide receptor on leukocytes is highly selective (5, 11, 24) . Structural requirements for optimal binding are reported to be (i) an N-formyl terminus substitution, (ii) a methionine at position 1, and (iii) hydrophobic amino acids at positions 2 and 3. Leucine and phenylalanine are the preferred amino acids at positions 2 and 3, respectively (11, 24) . Some degree of structural diversity is possible, with retention of biological activity (5, 11, 13, 24, 30, 32) Phe-L-Phe retain biological activity (11, 24) . Esters and amides of N-formyl peptides are active, the benzyl ester analog of FMLP, for example, being more active than the parent compound (11) . The phenylalanine residue of FMLP can be replaced with D-phenylglycine without significant loss of activity (30) ; substitution into the 4-position of phenylalanine (e.g., tyrosine) is not well tolerated (24) . Interestingly, the monocyclic 1-lactam antibiotic nocardicin A, a compound with only modest in vitro antibacterial activity, has immunostimulatory activity (2). This antibiotic has been reported to enhance the intracellular killing of Pseudomonas aeruginosa. In doses producing levels in blood well below the minimum bactericidal activity, this antibiotic successfully controlled an otherwise fatal pseudomonas infection in Since changes in the C-termin are tolerated, its replacement by amino acid residue may result in which combined good antibactei nostimulatory properties of FML lin with D-phenylglycine and D-p chains appeared, therefore, to b( for conjugation (30) . Several N-f ampicillin and amoxicillin were for antibacterial and immunostin
The peptide-antibiotic conjuga terial activity against both E. coi binding activity of the compounds and their potency as agonists. ED50s for chemotaxis were 3 to 4 times those for receptor binding, while ED5Os for stimulation of respiratory burst were 30 to 40 times those for receptor binding.
The D-amino acid side chains of ampicillin and amoxicillin should also increase the stability of the peptides to serum peptidases. N-Form-L-Met-Aib-ampicillin should be particularly stable since methyl-substituted amino acid residues greatly reduce lability to protease hydrolysis (17) . The in vivo activity of the conjugates may be greater than suggested ro2 -on --,0. by their in vitro potencies since serum half-lives should be prolonged. TION (,3 A further possible advantage of these peptide-antibiotic Is into micropore filters in reconjugates might be in the treatment of intracellular bacteria. cytogenes, and also some strains of Salmonella spp. and S. aureus which survive intracellularly following ingestion (26, 27) . N-Formyl peptide-receptor complexes are internalized some structural similarities following receptor binding, the peptide is transported to the Iycine moeity and 1-lactam cytosol, and the unoccupied receptor is recycled back to the nine and leucine residues of cell surface (15, 24) . Additional work is under way to nocardicin A did not bind to determine whether the peptide-antibiotic conjugates are also or stimulate the production internalized. 1-HL-60 cells (unpublished In summary, the four N-formyl peptide-penicillin conjugates synthesized were shown to exhibit good antibacterial ius phenylalanine of FMLP and immunostimulatory activity in in vitro assays. The in an antibiotic with a suitable vitro activity demonstrated by these compounds suggests the formation of a molecule that they warrant in vivo investigation. However, in vivo, rial activity with the immutheir potential usefulness may be limited since they may ,P. Ampicillin and amoxicilstimulate chemokinesis rather than chemotaxis and, in addi--hydroxyphenylglycine side tion, cause tissue damage at sites distant from the locus of e good candidate antibiotics infection through the widespread release of toxic oxygen ormyl peptide conjugates of radicals. For in vivo use, structural modifications may synthesized and evaluated therefore be necessary such that the immunostimulant pornulatory properties.
tion of the molecule requires activation by bacterial metabLtes displayed good antibacolism at the infection site. We are investigating the potential 1i and S. aureus, with MICs of such molecules. ranging from 1/4 to 1/20 those of the parent antibiotics ampicillin and amoxicillin. The stereochemistry at the leucine residue appeared to be important for activity against S. aureus. N-Form-L-Met-D-Leu-ampicillin was four times more active than the L-Leu isomer against this organism. This finding may reflect either differences in their affinity for the penicillin-binding proteins or the preferential penetration of the D-Leu isomer through the cell wall. Experiments are under way to investigate this phenomenon.
The receptor binding activity of the conjugates correlated with their structural similarity to the parent peptide FMLP. Thus, N-Form-L-Met-L-Leu-ampicillin, the nearest structural analog, had the greatest affinity for the chemotactic peptide receptor of the four ligands. Inversion of the stereochemistry at leucine reduced receptor binding by a factor of 2. N-Form-L-Met-D-Leu-amoxicillin, which possesses a Dp-hydroxyphenyl substituent, considerably reduced activity, a finding paralleled in the replacement of phenylalanine in FMLP by tyrosine (24) . The greatest reduction in receptor affinity was observed when the leucine residue was exchanged for Aib. The rationale for replacement with Aib was based on previous proposals that this residue locks the molecule into the biologically active receptor-binding conformation (13, 32) . However, this compound, which probably contains a p or y turn (13) , was about 100 times less active than FMLP.
There was also good correlation between the receptor-
